MeiraGTx Holdings Profit Margin 2017-2021 | MGTX
Current and historical gross margin, operating margin and net profit margin for MeiraGTx Holdings (MGTX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. MeiraGTx Holdings net profit margin as of June 30, 2021 is -325.94%.
|MeiraGTx Holdings Annual Profit Margins
|MeiraGTx Holdings Quarterly Profit Margins
||Medical - Biomedical and Genetics
MeiraGTx Holdings plc focuses on operating as a holding company for MeiraGTx Limited which operates as a clinical stage gene therapy company. It develops novel gene therapy treatments for inherited and acquired disorders. The company's product pipeline consists of AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, AAV-AQP1 and AAV-UPF1 which are in clinical stage. MeiraGTx Holdings plc is based in New York.